Literature DB >> 2460354

Renal and bladder function recovery after prostatectomy in patients with a chronic residual urine of above 1,000 ml.

I Nissenkorn1, M Savion, C Servadio.   

Abstract

Among 750 patients who underwent surgery because of benign prostatic hyperplasia, 26 (3.5%) were found, before surgery, to have a huge residual urine of over 1,000 ml without classic prostatic symptoms. Dilatation of the upper urinary tract was found in 22 (84.6%) of these 26 patients. After surgery, almost two thirds of the patients remained with the anatomical damage (dilatation) of the upper tract. Before surgery all the patients had elevated serum creatinine. After release of the obstruction 50% of the patients were left with irreversible renal damage (as determined by serum creatinine). Although anatomical changes of the urinary bladder remained in all the patients, a satisfactory clinical recovery with a fairly good detrusor contraction and almost no residual urine was found after surgical removal of the obstruction. Awareness of the entity described here followed by early treatment can prevent progressive renal failure and detrusor decompensation.

Entities:  

Mesh:

Year:  1988        PMID: 2460354     DOI: 10.1159/000473002

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

1.  Irreversible renal failure in men with outflow obstruction: is it a preventable disease?

Authors:  D E Neal
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

2.  Transurethral prostate surgery as a preventive method against progression of chronic kidney disease in patients with urodynamically proven bladder outlet obstruction.

Authors:  Dong Sup Lee; Hyung Wook Kim; Seung-Ju Lee
Journal:  World J Urol       Date:  2019-12-04       Impact factor: 4.226

3.  Perirenal fat stranding on CT: is there an association with bladder outlet obstruction?

Authors:  Na Y Han; Deuk J Sung; Min J Kim; Beom J Park; Ki C Sim; Sung B Cho
Journal:  Br J Radiol       Date:  2016-04-28       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.